Delivery Order V797D70252-36C25221F0060
Award Date
11/3/20
Potential Completion Date
11/30/20
Potential Value
$195K
Federal Agency
Veterans Integrated Service Network 12
Awardee
Gilead Sciences Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. for the supply of INV-REMDESIVIR 100MG (COVID-19) with a potential value of $175,162.50. The contract was awarded under Gilead's General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. Gilead will deliver the COVID-19 treatment medication directly to VA medical facilities. As a small business set-aside was...
The Department of Veterans Affairs Veterans Health Administration awarded a $291,937.50 firm fixed price delivery order to Gilead Sciences Inc. for the supply of the Veklury (remdesivir) drug for the treatment of COVID-19 patients. This delivery order was placed under Gilead's existing General Services Administration (GSA) Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). As a prime contractor, Gilead will directly provide the Veklury injections to VA medical facilities...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded Gilead Sciences Inc. a $136,237.50 firm-fixed-price delivery order contract for Veklury (remdesivir), a COVID-19 treatment. This order was placed against Gilead's existing Multiple Award Schedule (MAS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Gilead, a biopharmaceutical company, is the prime contractor and will directly provide the medication, with performance taking place in Foster City, California. This...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The order is for Veklury (remdesivir) to treat COVID-19, with a potential value of $194,625.00. As a Firm Fixed Price contract, Gilead will deliver the pharmaceutical product directly to VA medical facilities in Carrollton, TX. The award is not associated with a set-aside designation....
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc., a biopharmaceutical company, for the supply of the COVID-19 antiviral medication Veklury (remdesivir). The order has a firm-fixed price of $155,700.00 and a completion date of October 29, 2021. The contract was awarded on December 9, 2020 and is placed under Gilead's existing General Services Administration (GSA) Multiple Award Schedule contract for...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order contract to Gilead Sciences Inc., a biopharmaceutical company, to provide 100mg vials of the COVID-19 treatment drug remdesivir (branded as Veklury). The $155,700.00 firm fixed-price contract has a completion date of November 30, 2020 and is issued under Gilead's GSA Schedule 61-IB Pharmaceuticals and Drugs contract. This is one of several contracts the VA has awarded Gilead to supply antiviral and...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Gilead Sciences Inc. (Gilead) for the emergency procurement of the antiviral drug remdesivir (Veklury). The contract has a potential value of $194,625.00 and a completion date of December 31, 2020. This order is placed against Gilead's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Gilead, a biopharmaceutical company, has...
This is a federal contract award to Gilead Sciences Inc., a biopharmaceutical company, for the provision of REMDESIVIR 100MG SOLID. The contract was awarded on December 4, 2020 by the Department of Veterans Affairs Veterans Health Administration, with a potential value of $233,550.00. The contract is a Delivery Order under Gilead's General Services Administration (GSA) Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), indicating that Gilead is an established supplier of...
This is a delivery order contract awarded by the Department of Veterans Affairs to Gilead Sciences Inc. to provide Veklury (remdesivir) for COVID-19 treatment. The contract has a firm fixed price of $155,700.00 and a completion date of January 31, 2021. Gilead is a biopharmaceutical company that provides pharmaceuticals and biologics to government customers through its GSA Schedule contract. Gilead has received numerous federal contracts from the VA to supply antiviral and oncology...
This is a federal delivery order contract awarded by the Veterans Integrated Service Network 9 (VISN 9), part of the U.S. Department of Veterans Affairs (VA), to Gilead Sciences Inc. for the emergency procurement of the drug remdesivir. The contract has a ceiling value of $77,850.00 and was awarded on January 8, 2021, with a completion date of January 16, 2021. The contract was placed under GSA Schedule 61-IB for Pharmaceuticals and Drugs and utilized a firm fixed-price pricing type. This...